Whatever personal opinions in relation to the need for gender diversity on the board, this objective will have likely been mentioned to fulfill requirements of potential investors and customers, especially in the North American and European markets. Fluence has investors and partners in the ethical investment space, and these moreso than other investors require some semblance of equality measures on boards and management teams.
Fluence have also been attending meetings with local councilors in the USA for MABR approval in districts, which have some equality objectives. While Fluence had approval passed in New Mexico for one site, it should be noted that the Cabinet Secretary and Governor who visited the Israeli R&D site were both female and these types of business partners ask gender diversity questions.
The board is very large, but this is a complex company with operations on many continents, possibly necessitating the need for a broad range of experience across corporate deals, investing and financing. Cutting down the number may help with short term finances, but some of these board members are also large holders and the effects of someone like Richard Irving no longer having an interest in Fluence would be felt by all of us. It should be noted that the Top 20 holders have been quite strong with their holding for a number of years, it is the retail and smaller investment brokers that have fluctuated.
- Forums
- ASX - By Stock
- FLC
- Ann: Retirement of Peter Marks as a Director
FLC
fluence corporation limited
Add to My Watchlist
4.88%
!
3.9¢

Ann: Retirement of Peter Marks as a Director, page-27
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
3.9¢ |
Change
-0.002(4.88%) |
Mkt cap ! $42.32M |
Open | High | Low | Value | Volume |
4.1¢ | 4.1¢ | 3.8¢ | $17.54K | 451.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 6812 | 3.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.2¢ | 161616 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 6812 | 0.039 |
1 | 13250 | 0.038 |
2 | 370000 | 0.037 |
1 | 350000 | 0.036 |
2 | 220000 | 0.035 |
Price($) | Vol. | No. |
---|---|---|
0.042 | 161616 | 4 |
0.043 | 120000 | 1 |
0.045 | 25000 | 1 |
0.047 | 2224 | 1 |
0.050 | 67600 | 1 |
Last trade - 15.51pm 27/06/2025 (20 minute delay) ? |
Featured News
FLC (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online